You wouldn't think that having new drugs in the myeloma pipeline would actually be a challenge, but with an increase in new treatments also comes THE big question: Which therapy should each myeloma patient receive? Creating a clinical trial for each type of myeloma patient and each possible therapy combination could take decades. Drs. Morgan, Heuck, Weinhold, Epstein and Yaccoby propose the use of a mouse avatar that has your exact kind of myeloma. With this avatar, they can test how a drug or combination of drugs could act before the drugs are used in live patients, determining how effective they would truly be and shaving years off of important discoveries. The Myeloma Crowd Radio Show with Drs. Morgan, Heuck, Weinhold, Epstein and Yaccoby.